Epitheal is building a new kind of health company. Rooted in an apothecary tradition of compounding natural ingredients that stretches back generations. Powered by AI that learns from every product we develop, every submission we file, and every formulation decision we make.
For decades, skin recovery has meant one of two things: steroids or antibiotics. Both are under increasing pressure. Both were designed for a different era. Neither was built as a coherent skin recovery solution.
Pharmacists have always known there was a better way. The apothecary tradition of compounding natural ingredients for wound care goes back generations. That knowledge never disappeared. It just never had the infrastructure to scale. Until now.
Routine reliance on antibiotics for skin conditions is becoming untenable. Medicine needs credible alternatives, fast.
Skin thinning, withdrawal reactions, and mounting concern around repeated use are driving patients and clinicians to look elsewhere.
Infection, inflammation, dryness, cleansing. All treated as separate problems, never as a coherent recovery pathway.
The major players keep extending old active ingredients and formats. The natural-origin, formulation-led alternative simply hasn't existed.
Epitheal was built by pharmacists who grew up compounding natural ingredients. Not in a lab far removed from patients, but behind a counter, in a community, learning what actually worked. That craft knowledge is now the foundation of a platform designed to carry it forward at scale.
Developed by a compounding pharmacist drawing on a craft tradition of natural ingredient formulation. Not a reformulation of something existing. A genuinely new approach to what skin recovery can be.
Medical device wound care range launching now. A regulated medicine line in development. Veterinary applications in parallel. Each track strengthens the others.
The apothecary pharmacist learned by doing, and that learning compounded over a lifetime. Epitheal encodes that same principle into a platform: every formulation decision, every submission, every finding makes the next product faster and more defensible.
The apothecary pharmacist knew things that never made it into a textbook. Which combinations worked. Which didn't. Why a formulation behaved differently in different conditions. That knowledge lived in hands and memory. Epitheal is building the platform that captures it, connects it to the latest published research and patents, and turns it into a compounding advantage that grows with every product.
We're not waiting to be ready. The platform is live, the products are in motion, and the commercial foundation is being built now. Deliberately, before the higher-value medicine launch.
32 wound care SKUs ready for market. Launching through pharmacy and ecommerce channels to build brand presence, pharmacy relationships, and commercial proof.
In progressCore regulatory dossier preparation complete. Manufacturing readiness confirmed. Expert-reviewed claims substantiation finalised.
PlannedNúvaMend, the first regulated Epitheal medicine, launches subject to approval. Creates a repeatable pathway for future regulated skin recovery products.
PlannedBackend API, database, and authentication live on EU-hosted infrastructure. Knowledge capture sessions underway with the full team.
LiveFirst AI agent live: automatic patent and literature search against Epitheal's product set. Months of manual research compressed into hours.
Building170-document medicine submission automated. The full regulatory dossier, populated by AI using structured product and research data.
PlannedEvery decision at Epitheal is grounded in real-world pharmacist and pharma industry experience. This isn't a tech company that discovered healthcare.
Founder profile and background to be added. Commercial leadership across pharma and innovation sectors.
Compounding pharmacist whose practice stretches back to a tradition of preparing natural remedies by hand. The formulation knowledge at the heart of Epitheal began at his bench.
30 years across pharma manufacturing, regulatory affairs, and governance. Former executive at BBraun Ireland and GSK Ireland.
Leads the medicine regulatory submission programme. Expert on the full 170-document dossier pathway.
Business strategy, marketing, and new product development. Coordinating the commercial launch programme.
Procurement and Chinese manufacturing relationships. Overseeing the winner product range and supply chain.
Whether you're a potential investor, pharmacy partner, or just want to understand what we're building, we'd like to hear from you.
platform@epitheal.comEpitheal Limited · CRO 612186 · Gteic@AnSpidéal, An Spidéal, Galway